Open Science is a founding principle of ELIXIR, a pan-European research infrastructure for life science data, with 21 Member countries plus the European Molecular Biology Laboratory. The mission of ELIXIR is to coordinate bioinformatics resources so that they form a single, integrated and pan-European infrastructure, which can be used freely by academic and private-sector researchers across the globe. As a recipient of public and charitable funding, ELIXIR must demonstrate its value, and the need to produce evidence in support of this is intensifying. Our practice-led journey towards demonstrating public value is articulated around five main challenges and, for each, we present our pragmatic approach for tackling it. We begin by showing how we are working towards demystifying what research infrastructures do. We then shed light on the sort of evidence our funders and other stakeholders are asking us for, how this evidence varies in nature and scope, and our tactics to satisfy them. We follow-on by providing our thoughts on possible barriers and solutions to embedding impact evaluation in our activities. Finally, we provide lessons learned, which we believe are sufficiently transferable and will be inspirational to other research infrastructures as they embark on their own journeys to demonstrate public value.

中文翻译：

---

向资助者和其他利益相关者展示公共价值——ELIXIR 的旅程，生命科学数据的虚拟和分布式研究基础设施

开放科学是 ELIXIR 的创始原则，ELIXIR 是泛欧生命科学数据研究基础设施，拥有 21 个成员国和欧洲分子生物学实验室。ELIXIR 的使命是协调生物信息学资源，使它们形成单一、集成和泛欧洲的基础设施，可供全球学术和私营部门研究人员自由使用。作为公共和慈善资金的接受者，ELIXIR 必须证明其价值，并且越来越需要提供证据来支持这一点。我们以实践为导向的展示公共价值的旅程围绕五个主要挑战进行阐述，对于每个挑战，我们都提出了应对挑战的务实方法。我们首先展示我们如何努力揭开研究基础设施的神秘面纱。然后，我们阐明了我们的资助者和其他利益相关者要求我们提供的证据类型，这些证据在性质和范围上有何不同，以及我们满足他们的策略。我们随后就在我们的活动中嵌入影响评估的可能障碍和解决方案提供我们的想法。最后，我们提供了经验教训，我们认为这些经验教训具有充分的可借鉴性，并且会激励其他研究基础设施，因为他们开始展示公共价值。